113 related articles for article (PubMed ID: 2363416)
21. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
22. Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
Pich A; Godio L; Riera L; Cavaliere C; Kerim S; Bonello L; Francia di Celle P
Ann Hematol; 2016 Feb; 95(3):525-7. PubMed ID: 26750119
[No Abstract] [Full Text] [Related]
23. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
[TBL] [Abstract][Full Text] [Related]
24. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous occurrence of the 5q- syndrome and multiple myeloma.
Rios R; Sole F; Gascon F
Clin Lab Haematol; 2000 Feb; 22(1):49-53. PubMed ID: 10762305
[TBL] [Abstract][Full Text] [Related]
26. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
27. Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
Xue YQ; Guo Y; Lin BJ; Zhang GR; Lu DW; Wang MH; Gu YZ; Gong JX; Wang LX
Chin Med J (Engl); 1989 Sep; 102(9):689-94. PubMed ID: 2517082
[TBL] [Abstract][Full Text] [Related]
28. Therapy-related myelodysplastic syndrome. Two cytogenetically unrelated abnormal clones in a patient with multiple myeloma.
Abeliovich D; Yehuda O; Ben-Neriah S; Matzner Y
Cancer Genet Cytogenet; 1993 Oct; 70(2):117-9. PubMed ID: 8242590
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the 5q- chromosome.
Nagarajan L
Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow morphology in myelodysplastic syndrome associated with isolated del(5q).
Naresh KN; Reid A
Am J Hematol; 2010 Aug; 85(8):609-10. PubMed ID: 20658591
[No Abstract] [Full Text] [Related]
31. Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.
Jimenez-Sousa MA; Ferro MT; Talavera M; Villalon C; Cabello P; Laraña J; Herrera P; Garcia Sagredo JM
Cancer Genet Cytogenet; 2010 Dec; 203(2):345-7. PubMed ID: 21156257
[No Abstract] [Full Text] [Related]
32. [The 5q- syndrome associated with marked erythroid hypoplasia and Coombs test positive hemolysis].
Ohno T; Hishizawa M; Sugiyama T; Mizumoto T; Furukawa H
Rinsho Ketsueki; 1999 Jun; 40(6):499-504. PubMed ID: 10422288
[TBL] [Abstract][Full Text] [Related]
33. Gaucher disease and myelodysplastic syndrome with isolated del(5q).
Villarrubia J; Rodríguez-Gambarte JD; Abalo L; Vallés A; Alonso-Domínguez JM; Velasco-Rodríguez D
Br J Haematol; 2014 Apr; 165(2):164. PubMed ID: 24611589
[No Abstract] [Full Text] [Related]
34. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
[TBL] [Abstract][Full Text] [Related]
35. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome.
Kardos G; Veerman AJ; de Waal FC; van Oudheusden LJ; Slater R
Med Pediatr Oncol; 1996 Jan; 26(1):54-6. PubMed ID: 7494512
[TBL] [Abstract][Full Text] [Related]
36. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.
Douet-Guilbert N; De Braekeleer E; Basinko A; Herry A; Gueganic N; Bovo C; Trillet K; Dos Santos A; Le Bris MJ; Morel F; Eveillard JR; Berthou C; De Braekeleer M
Leukemia; 2012 Jul; 26(7):1695-7. PubMed ID: 22290067
[No Abstract] [Full Text] [Related]
38. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
[TBL] [Abstract][Full Text] [Related]
39. Homozygous deletion of FMS in a patient with the 5q- syndrome.
Boultwood J; Rack K; Buckle VJ; Kelly S; Madden J; Oscier DG; Wainscoat JS
Br J Haematol; 1990 Oct; 76(2):310-1. PubMed ID: 2094336
[No Abstract] [Full Text] [Related]
40. Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency.
Arcioni F; Roncadori A; Di Battista V; Tura S; Covezzoli A; Cundari S; Mecucci C;
Eur J Haematol; 2018 Jul; 101(1):78-85. PubMed ID: 29569278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
